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INTRODUCTION:  We described  the  case  of  a highly  aggressive  antral  gastric  carcinoma  with  a scarce
symptomatology,  in a patient  undergone  Roux-en-Y  Gastric  Bypass  (RYGB)  for obesity.
PRESENTATION  OF  CASE:  A 61  year-old  white  man  in  apparent  good  health,  who  underwent  laparoscopic
RYGB  for  obesity  18 months  earlier,  with  a loss  of  30 kg,  reported  a sudden  abdominal  distension  and
breath  shortness  with  a weight  gain  of  5 kg  in few days.  Endoscopy  of  both  upper  gastro-intestinal  tract
and the colon  were  performed  along  with  CT-scan  and  positron-emission  tomography  (PET)  CT-  scan.
A biopsy  of  the  palpable  lymph  node  in  the left  supraclavicular  fossa  was  taken  for analysis.  Abdominal
paracentesis  produced  milky  ﬂuid,  while  citrine  pleural  ﬂuid  was  aspirated  by  thoracentesis.  Immuno-
chemistry  studies  of the lymph  node  biopsy  revealed  tumor  cells  positive  for  cytokeratin  (CK)7  and
CK20,  CDX2  and CAM  5.2 and  negative  for HER2  and TTF1  suggesting  colon  cancer.  The  colon  and  upper
gastro-intestinal  endoscopy  were  normal.  A CT-scan  and  positron-emission  tomography  (PET)  with  2-
[ﬂuorine-18]ﬂuoro-2-deoxy-d-glucose  (FDG)  showed  an  intense  FDG-uptake  in  the  gastric  antrum  and  in
the  lymph  nodal  chains.  Given  these  ﬁndings,  a diagnosis  of  poorly  differentiated  antral  gastric  carcinoma
with  multiple  lymph  node  metastases  was  raised.The  patients  died  4 months  after diagnosis.
DISCUSSION:  RYGB  is  a  widely  performed  bariatric  operation  and  no data  are  reported  on  the  risk of
developing  gastric  cancer  in the  excluded  stomach.
CONCLUSION:  This  case  report  suggests  that  great  attention  should  be  devoted  to  post-RYGB  patients  for
an early  diagnosis  of malignant  gastric  cancer.
©  2016  The  Authors.  Published  by  Elsevier  Ltd  on  behalf  of  IJS Publishing  Group  Ltd.  This is  an  open
he  CCaccess  article  under  t
. Introduction
According to the epidemic increases in prevalence of obesity
n the last decades, the use of bariatric surgery is constantly on
he rise, not only to cure obesity itself but also to prevent obesity-
elated diseases, such as type 2 diabetes, cardiovascular diseases
nd respiratory diseases [1,2]. So far, one of the most commonly
tilized surgical procedure, even in adolescents, is Roux-en-Y Gas-
ric Bypass (RYGB) that can be performed laparoscopically, and it is
onsidered the “gold standard” treatment for morbid obesity. RYGB
onsists of creation of a small and vertically oriented gastric pouch
ith a volume usually less of 30 mL.  The upper pouch is completely
ivided by the gastric remnant and is anastomised to the jejunum,
0–75 cm distally to the ligament of Treitz, thus resulting in an
xclusion of a gastric portion to further endoscopic examination
1].
∗ Corresponding author at: Department of Internal Medicine, Catholic University,
argo A. Gemelli 8 00168 Rome, Italy.
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ttp://dx.doi.org/10.1016/j.ijscr.2016.10.077
210-2612/© 2016 The Authors. Published by Elsevier Ltd on behalf of IJS Publishing G
reativecommons.org/licenses/by-nc-nd/4.0/). BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).
A case of poorly differentiated antral gastric carcinoma with
multiple lymph node metastases, in spite of a scarce symp-
tomatology, is described, along with the diagnostic sequence and
confounding factors, resulting in a delayed diagnosis and a poor
prognosis.
2. Case summary
A 61 year-old white man  presented to our day-hospital of
Metabolic Diseases because of abdominal distension and breath
shortness of one week duration. He had been operated 18 months
earlier of laparoscopic RYGB for obesity and lost 30 kg in 1 year,
passing from a body mass index (BMI) of 41.8 to 31.7 kg/m2, and
thereafter maintained a constant weight while he was in apparent
good health and took no medications other than vitamin supple-
mentation. The patient noted a sudden weight gain of 5 kg in few
days. His medical history included heavy drinking (100 g alcohol
per day) and smoking habit with ca. 30–40 cigarettes daily for more
than 30 years. After the RYGB he continued smoking but stopped
drinking. He denied nausea, post-prandial discomfort or pain, diar-
roup Ltd. This is an open access article under the CC BY-NC-ND license (http://
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Fig. 1. A.B. Microphotograph of the poorly differentiated carcinoma with signet ring
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the histology of the supraclavicular lymph node were all in favor ofeatures. C. No immunohistochemistry staining was  seen for HER-2- Score 0 (Dako
olyclonal 1:400).
hoea, constipation, or decreased appetite. He did not refer of any
bdominal trauma.
Physical examination revealed the presence of abundant ascites,
 large right pleural effusion and a palpable lymph node in the left
upraclavicular fossa.Abdominal paracentesis produced 3000 mL  milky-ﬂuid rich in
riglycerides, while a total of 1500 mL  of citrine pleural ﬂuid was
spirated by thoracentesis.PEN  ACCESS
rgery Case Reports 29 (2016) 133–136
Transaminase, alkaline phosphatase, bilirubin, and albumin
were in a normal range. A CT-scan showed multiple mesenteric
and celiac lymphadenopathy with an average diameter of 1 cm.
Multiple enlarged retroperitoneal lymph nodes were also present.
No abnormality of the liver or pancreas were reported. Cytologic
examination of ascites showed malignant cells.
An incisional left supraclavicular lymph node biopsy was per-
formed and the sample was  submitted on parafﬁn sections for
immunochemistry studies with antibodies against several anti-
gens.
The tumour cells were positive for cytokeratin (CK)7 and CK20,
CDX2 and CAM 5.2 immunohistochemistry and negative for HER2
and TTF1 (Fig. 1).
The colonoscopy and the upper gastro-intestinal endoscopy
were normal. Bone metastases were excluded by scintigraphy.
A CT-scan and positron-emission tomography (PET) with 2-
[ﬂuorine-18]ﬂuoro-2-deoxy-D-glucose (FDG) detected an intense
FDG-uptake in the gastric antrum and in the lymph nodal chains
(Fig. 2). Given these ﬁndings, a diagnosis of poorly differentiated
antral gastric carcinoma with multiple lymph node metastases was
raised.
3. Discussion
Obesity prevalence is dramatically increased worldwide and
consequently, surgical procedures aimed to induce and maintain
weigh loss are largely increasing in the Western Countries, reach-
ing a plauteau of about 113,000 cases per year only in the United
States [1]. At the moment, there are no statistical data showing the
risk of gastric cancer in the excluded distal stomach after gastric
bypass for obesity.
The incidence of gastric cancer in the major part of Western
Countries is about 10–15 new cases per 100,000 inhabitants per
year, with a median age at diagnosis in the United States of 70 years
[3].
A decreasing incidence rate of distal gastric cancer has been
observed while tumors in the proximal stomach, i.e. cardia and gas-
troesophageal junction, are increasing [4]. It is well recognized that
Helicobacter pylori infection, dietary habits, smoking, and obesity
are risk factors for the development of gastric cancer.
The main manifestation of this clinical case was  the presence
of a chylous ascites resulting from the accumulation of a milk-like
peritoneal ﬂuid as a consequence of intestinal lymph metastasis.
Indeed, over two  thirds of all cases of chylous ascites are due
to abdominal malignancy that metastasize to mesenteric lymph
nodes [5]. Primary malignancies which more commonly result in
mesenteric lymph nodal involvement include carcinoma of the
lung, pancreas, and gastrointestinal tract [5,6].
The presence of a left supraclavicular lymph node, the so called
Virchow’s Node [7], can help the physician identify the visceral
origin of the tumor. The gastric origin of the lymph node metas-
tasis in this speciﬁc clinical case was unclear on the basis on the
immunohistochemistry. Cytokeratin, which forms the intermedi-
ate ﬁlaments of the cytoskeleton within both normal and malignant
epithelial cells, is commonly used as a marker of epithelial cells.
The multi-marker phenotype CK20-CK7-CK2 is generally applied
to identify colorectal cancer metastasis. Tumor cells expressing
positive immunoreactivity to low molecular weight cytokeratin
(CAM 5.2), in combination with CK 20, CK 7 is useful to distinguish
primary lung carcinoma (CK7+/CK20-) from primary colonic carci-
noma (CK7-/CK20+) [8]. Therefore, the indications obtained froma primary colorectal carcinoma.
Great attention, however, should be given to the stomach rem-
nant in RYGB patients, even when the CT scan is negative for mass
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Fig. 2. Fluorine-18 ﬂuorodeoxyglucose Positron Emission Tomography (18F-FDG PET) image (on the left) showed an area of abnormal increased radiopharmaceutical uptake
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un  the epigastrium (red arrow), corresponding to the stomach wall at axial CT and 
abolic  lymphadenopathies (yellow arrows) in the cervical, thoracic and abdomino
ypermetabolic lymphadenopathies (D) are showed at axial CT and fused PET/CT im
etection. In fact, since up to 80% of patients are asymptomatic
uring the early stages of the gastric cancer the diagnosis is often
elayed and 2/3 of the cases are discovered only after local invasion
s advanced [9]. Abdominal pain, nausea, early satiety and vomit-
ng, associated with weight loss can accompany late-stage gastric
ancer. In the present case the symptoms were absent probably
ecause the cancer arose from the excluded stomach and, there-
ore, there was no contact with food which can cause gastric pain
fter eating.
Esophagogastroduodenoscopy (EGD) is the imaging procedure
f choice in the diagnosis of gastric carcinoma [10]. Endoscopic
ltrasonography is currently the most reliable method for T stage
etermination, and shows a diagnostic rate between 78% and 93%
11,12]. In our case the upper gastro-intestinal endoscopy, which
ould explore only the small gastric pouch and the efferent small
owel limb, was normal and ultrasonography could not have pro-
ided helpful images since the cancer site was in the excluded
tomach.
Primary tumor location in the stomach can be correctly identi-
ed by spiral CT in up to 77% of cases. However, CT is not a good
ethod to differentiate normal lymph nodes from those containing
etastases, showing a sensitivity which ranges from 48 to 82% and
 speciﬁcity lower than 62% [13–15].
In the present case, contrast enhanced CT was unable to identify
he primary gastric cancer. Although PET is considered to be not
elpful in T staging because it is a functional imaging modality,
ere it allowed to detect the primary tumor.
The use of routine preoperative upper GI endoscopy before
ariatric surgery is controversial since it can be associated with relatively high risk in morbidly obese subjects [16]. Although,
ollowing the European guidelines that recommend preoperative
pper GI endoscopy in all subjects [17], our patient underwent
pper GI examination before RYGB, he developed metastatic gas-PET/CT images (A), respectively. 18F-FDG PET/CT also detected multiple hyperme-
c regions. In particular left cervical (B), left axillary (C) and bilateral external iliac
 respectively.
tric cancer 18 months after surgery. Indeed, he had a series of risk
factors, such as smoking and drinking habits.
Since after RYGB the majority of the stomach is inaccessible to
conventional endoscopy, the CT-PET can be very useful for an early
diagnosis of a gastric cancer in these patients. Unfortunately, in the
staging of gastric cancer, involvement of the supraclavicular lymph
node is considered distant metastasis rather and precludes curative
surgery and, thus, the diagnosis in our clinical case was done too
late to permit the chance of cure. The patient died 4 months after
diagnosis.
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